AKT1 and small cell lung carcinoma: In summary, our study showed that Tan IIA suppresses the proliferation and metastasis of SCLC by inhibiting the PI3K/Akt signaling pathway, thus highlighting Tan IIA as a potential therapeutic drug for SCLC.